Buccoadhesive slow-release tablets of acitretin: Design and 'in vivo' evaluation

International Journal of Pharmaceutics

Volumn 169, Issue 2, 1998, Pages 195-202

  Minghetti, P ^a   Colombo, A ^a   Montanari, L ^a   Gaeta, G M ^b   Gombos, F ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Acitretin; Buccoadhesive tablets; Keratinization disorders

Indexed keywords

AROTINOID; CARBOMER; ETRETIN; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG SALIVA LEVEL; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LEUKOPLAKIA; MALE; MOUTH CAVITY; ORAL DRUG ADMINISTRATION; PHOTODEGRADATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; SUSTAINED RELEASE PREPARATION; TABLET; TOPICAL DRUG ADMINISTRATION; VISCOSITY;

EID: 0032528409     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00119-7     Document Type: Article

References (16)

1. Barbagna A., Mariani E., Dorato S. TLC, HPTLC and HPLC determination of cis- and trans-retinoic acids, retinol and retinyl acetate in topically applied products. Acta Tech. Leg. Med. 2:1991;75-86.
2. Blanchet-Bardon C., Nazzaro V., Rognin C., Geiger J.M., Puissant A. Acitretrin in the treatment of severe disorders of keratinization. Therapy. 24:1991;982-986.
3. Bouckaert S., Remon J.P. In vitro bioadhesion of a buccal Miconazole slow-release tablet. J. Pharm. Pharmacol. 45:1993;504-507.
4. Bouckaert S., Schautteet H., Lefebre R.A., Remon J.P., Van Clooster R. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel. Eur. J. Clin. Pharmacol. 43:1992;137-140.
5. Dittgen M., Oestereich S. Development of a bioadhesive oral drug delivery system. I. Basic Investigation. STP Pharma. 5:1989;867-870.
6. Gaeta, G.M., Minghetti, P., Majorana, A., 1997. A new mucoadhesive drug delivery system for the release of acitretin in the treatment of oral leukoplaklas. Oral Sur., Oral Med., Oral Pathol. 84 (2), 161-162.
7. Junginger H.E. Mucoadhesive hydrogels. Pharm. Ind. 53:1991;1056-1065.
8. Laugier J.P., Surber C., Bun H., Geiger J.M., Wilhelm K.P., Durand A., Maibach H.I. Determination of Acitretin in the skin, in the suction blister, and in plasma of human volunteers after multiple oral dosing. J. Pharm. Sci. 83:1994;623-628.
9. Mortazavi S.A., Smart J.D. An in vitro method for assessing the duration of mucadhesion. J. Control. Release. 31:1994;207-212.
10. Nair M.K., Chien Y.W. Development of anticandidal delivery systems: (II) Mucoadhesive devices for prolonged drug delivery in the oral cavity. Drug Dev. Ind. Pharm. 22:1996;243-253.
11. Ponchel G., Touchard F., Wouessidjewe D., Duchene D., Peppas N.O. Bioadhesive analysis of controlled release systems. III. Bioadhesive and release behaviour of Metronidazole-containing poly(acrilic acid)-hydroxypropyl methylcellulose systems. Int. J. Pharm. 38:1987;65-70.
12. Serpico, R., Gaeta, G.M., Femiano, F., Busciolano, M., 1994. Derivati vitaminici in patologia orale. Proc. I Congresso SIPO, Napoli, Italy.
13. Smart J.D. Drug delivery using buccal-adhesive systems. Adv. Drug Del. Rev. 11:1993;253-270.
14. Spah V.P., Konecny J.J., Everett R.L., McCoullogh B., Noorizadeh A.C., Skelly J.P. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res. 6:1989;612-618.
15. The stability testing of new drug substances and products - The tripartite guideline. USP 23 (1995) <1196> 1960.
16. Wan L.S.C., Heng P.W.S., Wong L.F. Relationship between swelling and drug release in a hydrophilic matrix. Drug Dev. Ind. Pharm. 19:1993;1201-1210.